For Immediate Release For Further Information Contact:
June 19, 2014 Thomas Toland
949-698-8485 mobile
SURGLINE UPDATE ON ALLERGY PRODUCT LAUNCH
WEST PALM BEACH, Fla., June 19, 2014 SurgLine International, Inc. (SGLN.PK)
SurgLine International, Inc. and its wholly owned subsidiary SurgLine Inc. will launch a physician office allergy testing program using Sublingual Immunotherapy also known as SLIT.
As an update, SurgLine is awaiting final approval from the manufacturer as to final labeling requirements from the FDA for the allergy product. The manufacturer has received an expedited appointment with the FDA and is confident that it will receive the necessary approvals to launch its product offering.
SurgLine will commence its marketing of the product as soon as it is notified. The manufacturer has not given SurgLine a date specific for the intended launch until it receives the required letter.
SurgLine will provide an update as soon as it has the updated information to report.
McKesson is the registered trademark of McKesson Corporation and Henry Schein is the registered trademark of Henry Schein, Inc.
SurgLine continues to participate in the MedPassage ecosystem and anticipates that the MedPassage ecosystem will continue to gain market share awareness in the coming year to which SurgLine will benefit from sale of its products and aggressive pricing strategies.
Keywords: Henry Schein, McKesson, Medical, Dental, Veterinarian, Hospitals, Clinics, Physician, Practices, Savings, Laboratories, SurgLine, SurgLinesavings.com, Savings, direct ship.
Forward Looking Statements
This update release may contain forward-looking statements, including information about management’s view of future expectations, plans and prospects for SurgLine International, Inc. (the "Company"). In particular, when used in the preceding discussion, the words "predicts", "believes", "expects", "intends", "seeks", "estimates", "plans", "anticipates", and similar conditional expressions or future or conditional verbs such as "will", "may", "might", "should" "would" and "could" are intended to identify forward-looking statements. In addition, our representatives may from time to time make oral forward-looking statements. Any such statements, other than those of historical fact, about an action, event or development are forward-looking statements. Such statements are based on the current expectations and certain assumptions of the Company’s management. Such statements are, therefore, subject to a variety of known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company, which could cause the actual results, performance, its subsidiaries and concepts to be materially different than those that may be expressed or implied in such statements or anticipated on the basis of historical trends. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company’s actual results, performance or achievements may vary materially from those described in the relevant forward-looking statements as bine expected, anticipated, intended, planned, believed, sought, estimated or projected. Unknown or unpredictable factors also could have material adverse effects on the Company’s future results. The forward-looking statements included herein are made only as of the date hereof. The company cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, the company undertakes no obligation to update or revise these forward-looking statements to reflect the impact of circumstances or events that arise after the date of the forward-looking statement was made, except as required by law, and also takes no obligation to update or correct information prepared by third parties that re not paid for by the Company. You should not place undue reliance on any forward-looking statement and should consider the uncertainties and risks discussed under item, "Risk Factors" of the Company’s annual Report on Form 10-K for the year ended July 31, 2014 and in any of the Company’s other subsequent Securities and Exchange Commission filings.
